The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

P S C Rees; S M Davidson; S E Harding; C McGregor; P M Elliot; D M Yellon; D J Hausenloy

doi:10.1007/s10557-013-6447-z

The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

P S C Rees, S M Davidson, S E Harding, C McGregor, P M Elliot, D M Yellon, D J Hausenloy

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	235-7
Number of pages	3
Journal	Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy
Volume	27
Issue number	3
DOIs	https://doi.org/10.1007/s10557-013-6447-z
Publication status	Published - Jun 2013

Keywords

Atorvastatin Calcium
Cardiomyopathy, Hypertrophic
Cardiotonic Agents
Cells, Cultured
Cyclosporine
Heptanoic Acids
Humans
Ion Channel Gating
Membrane Potential, Mitochondrial
Microscopy, Confocal
Mitochondria, Heart
Mitochondrial Membrane Transport Proteins
Myocardial Reperfusion Injury
Myocytes, Cardiac
Pyrroles
Time Factors

Access to Document

10.1007/s10557-013-6447-z

Cite this

Rees, P. S. C., Davidson, S. M., Harding, S. E., McGregor, C., Elliot, P. M., Yellon, D. M., & Hausenloy, D. J. (2013). The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 27(3), 235-7. https://doi.org/10.1007/s10557-013-6447-z

@article{b1f9ddecd68445bb9d2fb7c8e295a4cc,

title = "The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy",

keywords = "Atorvastatin Calcium, Cardiomyopathy, Hypertrophic, Cardiotonic Agents, Cells, Cultured, Cyclosporine, Heptanoic Acids, Humans, Ion Channel Gating, Membrane Potential, Mitochondrial, Microscopy, Confocal, Mitochondria, Heart, Mitochondrial Membrane Transport Proteins, Myocardial Reperfusion Injury, Myocytes, Cardiac, Pyrroles, Time Factors",

author = "Rees, {P S C} and Davidson, {S M} and Harding, {S E} and C McGregor and Elliot, {P M} and Yellon, {D M} and Hausenloy, {D J}",

year = "2013",

month = jun,

doi = "10.1007/s10557-013-6447-z",

language = "English",

volume = "27",

pages = "235--7",

journal = "Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "3",

}

Rees, PSC, Davidson, SM, Harding, SE, McGregor, C, Elliot, PM, Yellon, DM & Hausenloy, DJ 2013, 'The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy', Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, vol. 27, no. 3, pp. 235-7. https://doi.org/10.1007/s10557-013-6447-z

The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy. / Rees, P S C; Davidson, S M; Harding, S E et al.
In: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, Vol. 27, No. 3, 06.2013, p. 235-7.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

AU - Rees, P S C

AU - Davidson, S M

AU - Harding, S E

AU - McGregor, C

AU - Elliot, P M

AU - Yellon, D M

AU - Hausenloy, D J

PY - 2013/6

Y1 - 2013/6

KW - Atorvastatin Calcium

KW - Cardiomyopathy, Hypertrophic

KW - Cardiotonic Agents

KW - Cells, Cultured

KW - Cyclosporine

KW - Heptanoic Acids

KW - Humans

KW - Ion Channel Gating

KW - Membrane Potential, Mitochondrial

KW - Microscopy, Confocal

KW - Mitochondria, Heart

KW - Mitochondrial Membrane Transport Proteins

KW - Myocardial Reperfusion Injury

KW - Myocytes, Cardiac

KW - Pyrroles

KW - Time Factors

U2 - 10.1007/s10557-013-6447-z

DO - 10.1007/s10557-013-6447-z

M3 - Article

C2 - 23380984

SN - 0920-3206

VL - 27

SP - 235

EP - 237

JO - Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy

JF - Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy

IS - 3

ER -